The stock decreased 1.61% or $0.06 during the last trading session, reaching $3.67. About 417,808 shares traded. Aptose Biosciences Inc. (NASDAQ:APTO) has declined 60.81% since March 18, 2017 and is downtrending. It has underperformed by 77.51% the S ...
more»